Literature DB >> 5211353

The antiparkinson properties of amantadine in drug-induced parkinsonism.

J T Kelly, F S Abuzzahab.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5211353

Source DB:  PubMed          Journal:  J Clin Pharmacol New Drugs        ISSN: 0021-9754


× No keyword cloud information.
  6 in total

Review 1.  Towards medication-enhancement of cognitive interventions in schizophrenia.

Authors:  Hsun-Hua Chou; Elizabeth Twamley; Neal R Swerdlow
Journal:  Handb Exp Pharmacol       Date:  2012

2.  Are we studying and treating schizophrenia correctly?

Authors:  Neal R Swerdlow
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

3.  Urinary excretion of amantadine by the elderly.

Authors:  C Montanari; P Ferrari; A Bavazzano
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

4.  Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.

Authors:  G M Pacifici; M Nardini; P Ferrari; R Latini; C Fieschi; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

Review 5.  Tourette's syndrome and role of tetrabenazine: review and personal experience.

Authors:  Mauro Porta; Marco Sassi; Mario Cavallazzi; Maurizio Fornari; Arianna Brambilla; Domenico Servello
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

6.  Inappropriate modeling of chronic and complex disorders: How to reconsider the approach in the context of predictive, preventive and personalized medicine, and translational medicine.

Authors:  Soroush Seifirad; Vahid Haghpanah
Journal:  EPMA J       Date:  2019-07-31       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.